Chemoinformaics analysis of (9S,10S)-9,10-DIHYDROXYSTEARIC ACID
| Molecular Weight | 316.482 | nRot | 16 |
| Heavy Atom Molecular Weight | 280.194 | nRig | 1 |
| Exact Molecular Weight | 316.261 | nRing | 0 |
| Solubility: LogS | -3.302 | nHRing | 0 |
| Solubility: LogP | 4.628 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 57.2725 |
| nHD | 3 | BPOL | 36.9835 |
| QED | 0.371 |
| Synth | 2.842 |
| Natural Product Likeliness | 0.809 |
| NR-PPAR-gamma | 0.971 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.072 |
| Pgp-sub | 0.004 |
| HIA | 0.094 |
| CACO-2 | -5.214 |
| MDCK | 0.0000397 |
| BBB | 0.152 |
| PPB | 0.973805 |
| VDSS | 0.481 |
| FU | 0.0144387 |
| CYP1A2-inh | 0.083 |
| CYP1A2-sub | 0.181 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.092 |
| CYP2c9-sub | 0.987 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.081 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.014 |
| CL | 3.831 |
| T12 | 0.808 |
| hERG | 0.068 |
| Ames | 0.008 |
| ROA | 0.009 |
| SkinSen | 0.408 |
| Carcinogencity | 0.044 |
| EI | 0.471 |
| Respiratory | 0.342 |
| NR-Aromatase | 0.15 |
| Antiviral | Yes |
| Prediction | 0.603706 |